Preoperative Methods to Reduce Liver Volume in Bariatric Surgery: a Systematic Review by unknown
ORIGINAL CONTRIBUTIONS
Preoperative Methods to Reduce Liver Volume in Bariatric
Surgery: a Systematic Review
J. van Wissen1,2,3 & N. Bakker1,2,3 & H. J. Doodeman1,3 &
E. P. Jansma2 & H. J. Bonjer2 & A. P. J. Houdijk1,2,3
Published online: 30 June 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Background Patients qualified for gastric bypass surgery have
an enlarged and fatty liver. An essential step in gastric bypass
surgery is elevation of the left liver lobe to expose the gastro-
esophageal junction. An enlarged and fatty liver complicates
the surgical procedure and increases the risk for laceration of
the liver. The aim of our study was to evaluate methods to
reduce liver volume in patients prior to gastric bypass surgery.
Methods A systematic literature search of multiple databases,
including PubMed, EMBASE.com, and the Cochrane Library
and a hand search of reference lists, was performed. We used
the search terms morbid obesity and liver, including their syn-
onyms and controlled terms. Inclusion criteria were as fol-
lows: patients with morbid obesity who qualified for bariatric
surgery, the use of a preoperative treatment to reduce liver
volume, and the use of imaging techniques before and after
treatment.
Results In total, 281 patients in 11 different studies were in-
cluded. Preoperative diets reduced liver size by an average of
14 %, alternative methods including nutritional supplements,
reduced liver size between 20 and 43 %, and an intragastric
balloon by 32 %.
Conclusions This review showed that nutritional supplements
and intragastric balloon are more effective than low calorie
diets in reducing liver volume prior to gastric bypass surgery.
However, low calorie diet is the preferable method to reduce
liver volume, considering the level of evidence and practical
applicability. There is a need for well-designed randomized
studies with sufficient power in order to confirm the effective-
ness of preoperative methods to reduce liver volume.
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Introduction
Morbid obesity is a growing global problem with an increas-
ing number of patients in need for bariatric surgery. In the past
decade, the prevalence of morbid obesity in the USA has
increased by 70 %, from 2.1 % in 2000 to 3.7 % in 2010 [1].
Laparoscopic Roux-en-Y gastric bypass (LRYGBP) is the
gold standard in Europe and the USA and successfully re-
duces weight in patients with morbid obesity [2]. Patients
qualified for LRYGBP often have an enlarged and fatty liver.
The prevalence of steatosis and steatohepatitis in patients
qualified for bariatric surgery varies between 52 and 90 %
and between 33 and 89 %, respectively [3–9]. An enlarged
and fatty liver complicates LRYGBP in two ways. First, the
enlarged left liver lobe complicates the approach to the gas-
troesophageal junction. Second, the soft fatty liver is vulnera-
ble and thereby increasing the risk of bleeding upon surgical
manipulation. For these reasons, an enlarged and fatty liver is
the most common reason for conversion from laparoscopic to
open Roux-en-Y gastric bypass [10]. The overall conversion
rate in LRYGBP is approximately 4 %, and an enlarged liver
is responsible for approximately 50% of the conversions [11].
Currently, a preoperative low calorie diet is recommended
in patients qualified for LRYGBP in order to reduce liver
volume and facilitate surgery [12–22]. The duration and
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content of the diet differ per country and per institution. There
are also pharmacological and endoscopic measures to reduce
liver volume that could be an alternative for preoperative
diets.
The objective of this systematic review was to investigate
the effectiveness of different preoperative methods to reduce
liver volume in patients qualified for bariatric surgery.
Methods
Data Sources
We conducted a systematic literature search to identify studies
relevant to the review. Initially broad search terms were used,
including [MORBID OBESITY], [PREOPERATIVE
CARE], [LIVER VOLUME], AND [BARIATRIC SUR-
GERY], including their synonyms and controlled terms. The
search was performed in multiple databases, including
PubMed, EMBASE.com, and the Cochrane Library (via Wi-
ley) from inception to November 6, 2013. The search strategy
for PubMed included the following search terms: BObesity,
Morbid^ [Mesh] OR Bmorbid obesity^ [tiab] OR Bmorbidly
obese^ [tiab] OR Bexcess body weight^ [tiab] AND BLiver^
[Mesh] OR Bliver^ [tiab]. The search strategy for EMBASE
included the following search terms: Bmorbid obesity^/exp
OR Bmorbid obesity^:ti,ab OR Bmorbidly obese^:ti,ab OR
Bexcess body weight^:ti,ab AND Bliver^/exp OR liver:ti,ab.
The search strategy for the Cochrane Library included the
search terms Bmorbid obesity^ AND Bliver.^ The electronic
search was supplemented by a hand search of reference lists of
the available relevant literature. The search was performed by
one of the authors (EJ).
Data Selection
Studies focusing on preoperative methods to reduce liver vol-
ume in patients qualified for bariatric surgery were included.
The exact inclusion criteria were as follows: studies in patients
undergoing bariatric surgery for treatment of morbid obesity,
studies that investigated methods to reduce liver volume as
pretreatment before bariatric surgery, and studies that used
radiographic measurements of total liver volume or volume
of left hepatic lobe.
Statistical analysis
A meta-regression analysis on the studies focusing on the
effect of preoperative LCD’s was performed. The separate
effect of the amount of calories and the duration of the LCD
on liver volume was analyzed, taking the number of patients
in each study as a weighing factor. Statistical analyses were
performed using SPSS (Statistical Package for the Social Sci-
ences, version 20, 2009, Chicago, IL, USA).
Results
Study Characteristics
The initial search yielded a total of 1897 references. Two
researchers (JW and NB) independently screened titles and
abstracts for relevance. After removing duplicates of refer-
ences that were selected from more than one database, 1310
references remained. From these, 1283 references were ex-
cluded because they were not relevant to the study. From the
remaining 27 articles, full texts were screened for relevance.
Finally, 11 studies were found eligible involving a total of 281
patients. The process of data selection is summarized in Fig. 1.
Data Evaluation
In total, 9 prospective observational studies, 1 retrospective
observational study, and 1 retrospective case-matched-control
study were included. Seven studies (60 % of all patients) in-
vestigated the effect of a preoperative low calorie diet, 3 stud-
ies (29 % of all patients) focused on preoperative pharmaco-
logical measures, and in 1 study (11 % of all patients), the
effect of a preoperative intragastric balloon on liver volume
was evaluated. Overall, 59 % of the patients were women,
27 % were men, and in 14 %, gender was not described.
Themean age of the studied patients varied from34 to 48 years
of age. The nine cohort studies that were included showed
considerable heterogeneity in terms of patient population,
sample sizes, intervention methods, and assessment of out-
come. Only two studies had a controlled design. Edholm
et al. [17] used a control group with the same gender and
approximately the same sample size as the intervention group.
The method of selection of the control group was not reported.
Aberle et al. [12] used a retrospectively matched control
group.
Preoperative Low Calorie Diet
In total, seven studies [13, 15–18, 20, 22] investigated the
effect of a preoperative low calorie diet on liver volume. The
median duration of the preoperative diet was 6 weeks (range
2–12 weeks). The amount of calories ranged from a minimum
of 456 kcal/day to a maximum of 1520 kcal/day. Body mass
index (BMI) before preoperative diet ranged from 43 to 56 kg/
m2. Themedian change in BMI after the low calorie diet was a
reduction of 9.1 % (range 4.2–12.5 %). The median change in
liver volume was a reduction of 15 % (range 5–20 %). The
weighted average of change in liver volume was 14 %. Gen-
erally, longer duration of the diet showed more reduction in
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liver volume. However, the maximum percentage of change in
liver volume did not correspond with the maximal duration of
the diet or the minimum amount of calories per day. An over-
view of the effect of preoperative low calorie diets is shown in
Table 1.
Meta-Regression Analysis
Taking the number of patients in each study as a weighing
factor, the mean reduction in liver volume is −13.6 % (SD
5.8), which is the result of a mean number of 729 kcal per
day (SD 286) during a mean number of 6.4 weeks (SD 3.6).
Using the same weighing factor in a linear regression analysis,
the resulting constant (β0) is −3.294, and the regression coef-
ficients for the number of kilocalories and number of weeks
(β1 and β2) are −0.002 and −1.372, respectively. In other
words, a low calorie diet of 500 kcal during 3 weeks for
example would result in a reduction in liver volume of
(−3.294+(500* −0.002)+(3*−1.372)=−8.41 %.
Alternative Preoperative Measures
Three studies [12, 14, 21] investigated the effect of alternative
preoperative measures on liver volume. Aberle et al. [12]
studied the effect of 15 mg sibutramine for 6 weeks in a ret-
rospective case-matched-control study. Patients in the group
treated with sibutramine lost an average of 4.8 kg and the
matched control group gained an average of 7 kg in 6 weeks.
The greatest decrease was seen in the longitudinal measure-
ments of the right hepatic lobe in the group treated with
sibutramine (mean decrease of 1.9±2.2 cm). Brody et al.
[14] investigated the effect of Nuvista® together with a low
Fig. 1 Flowchart of study inclusion
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calorie diet (1200–1500 kcal/day) for 4 weeks. Ianelli et al.
[21] investigated the effect of 1500 mg omega-3 fatty acids a
day for 4 weeks without any dietary restrictions. An overview
of preoperative alternative measures is shown in Table 2.
Endoscopic Measures
Frutos et al. [19] investigated the effect of an intragastric bal-
loon for 6 months prior to LRYGBP in super obese (BMI>
50 kg/m2). Mean BMI decreased from 55.2±6.9 to 47.4±
7.7 kg/m2. Liver volume was measured by CT and decreased
from 2938.5±853.1 to 1918±499.8 cm3 (31.8 %).
Approach of Gastroesophageal Junction
Three studies [13, 15, 22] investigated the effect of a preoper-
ative low calorie diet and reported a relatively easy approach
of the gastroesophageal junction during LRYGBP. Colles
et al. [15] also reported that none of the surgical procedures
were converted from laparoscopic to open. Lewis et al. [22]
also reported a soft liver that could easily be manipulated
during surgery by using a very low calorie diet. Ianelli et al.
[21] reported no difficulties in the approach of the gastro-
esophageal junction in patients treated with omega-3 polyun-
saturated fatty acids. In addition, the liver could be easily
retracted during surgery.
Discussion
This study included 7 studies that investigated the effect of
low calorie diets on liver volume in 6 different countries,
including Israel, Australia, New Zealand, USA, Mexico, and
Sweden. The duration and the content of the diets varied wide-
ly between the studies. All studies reported a reduction in liver
volume varying from 5 to 20 %.
The lowest reduction in liver volume was associated with
the shortest duration of the diet. Studies with a longer duration
of the diet showed on average more reduction in liver volume
by approximately 2.4 % per week. This indicates that the
duration of the diet correlates with the amount of reduction
of liver volume. However, the highest reduction in liver vol-
ume was not associated with the longest duration of the diet or
the lowest amount of calories, suggesting that the content of
the diet, i.e. the amount of protein, carbohydrates, and fat, also
plays an important role in reducing liver volume.
Meta-regression analysis showed that the effect of the
amount of calories is marginal compared to the effect of the
number of weeks of the LCD. Although the number of studies
is considered not sufficient for a robust meta-regression anal-
ysis, it is remarkable that the amount of calories has no effect
on liver volume. These results suggest that any kind of diet
will reduce liver volume and that the focus should lie on the
duration of the diet and the adherence.
Table 1 Overview of preoperative low calorie diets

















2007 Benjaminov Prospective 14 4 1520±285 −5.1 Liver CT −8.2 −2.1
2006 Colles Prospective 32 12 456–680 −10.6 Liver MRI / CT −18.7 −1.6
2011 Collins Retrospective 30 9 800 −12.5 Liver CT −18 −2.0
2011 Edholm Prospective 15 4 800–1100 −6.1 Liver MRI −12 −3.0
2004 Fris Prospective 40 2 456 −4.2 Left lobe Ultrasound −5.1 −2.6
2013 Gonzalez-Perez Prospective 20 6 800 −12.2 Liver CT −20.3 −3.4
2006 Lewis Prospective 18 6 450–800 −9.1 Liver MRI −14.7 −2.5
Table 2 Overview of alternative preoperative measures


















6 Sibutramine Left lobe Ultrasound n.a. n.a.
2011 Brody Prospective 21 4 Nuvista® and low calorie diet Left lobe Ultrasound −43.4 −10.9
2013 Ianelli Prospective 20 4 Omega-3 fatty acids Left lobe Ultrasound −20.0 −5.0
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A downside of a low calorie diet is that it is relatively
expensive and burdensome for the patient. Common side ef-
fects of dietary foods are nausea, vomiting, stomach discom-
fort, and constipation. In addition, patients often have difficul-
ties with adherence to the diet. Another serious drawback of
this method is that low calorie diets for multiple weeks may
induce a catabolic state, which could be a disadvantage in
recovery after surgery.
All studies that investigated the effect of low calorie diets
had several limitations. First, all studies used a relative small
number of patients, varying between 14 and 40 patients. Sec-
ond, there was a lack of well-designed randomized studies.
Six studies were prospective observational, 1 study was retro-
spective, only 1 study used a control group, and none of the
studies was designed as a randomized controlled trial. In ad-
dition, none of the studies performed a power calculation.
Three studies investigated the effect of alternative measures
to reduce liver volume. Aberle et al. [12] investigated the
effect of sibutramine on BMI and liver volume compared to
a case-matched-control group in a retrospective study.
Sibutramine is a centrally acting serotonin-norepinephrine re-
uptake inhibitor developed for the treatment of obesity. It in-
creases the metabolism; it induces an earlier feeling of satiety
and is thereby a successful method to reduce weight. [23]
Patients were advised to use sibutramine prior to surgery and
retrospectively compared the group that had used sibutramine
with a historic control group. This design has such a high
probability of selection bias, that it is hard to draw any
conclusions.
Brody et al. [14] studied the effect of the nutritional sup-
plement Nuvista® combined with a low calorie diet. Nuvista®
is a nutritional supplement that consists of a high protein con-
tent and a wide range of vitamins and minerals. They reported
the greatest decrease in liver volume (43 %) of all studies.
Unfortunately, they did not use a control group; so, the addi-
tional effect of Nuvista® cannot be determined. But, the com-
bination of Nuvista® and a low calorie diets seems to be the
most effect way to reduce liver size.
Ianelli et al. [21] investigated the effect of omega-3 fatty
acids on liver volume and found a reduction of 20% of the left
hepatic lobe. The results of this study are promising, because
they proved that it could be an effective method to reduce liver
volume without the need for dietary restrictions. A limitation
of this study is that they only reported the BMI at baseline and
not after treatment with omega-3 fatty acids. Therefore, it is
uncertain whether the reduction in liver volumewas caused by
the use of omega-3 fatty acids alone or that weight loss could
also have played a role.
Only one study [19] reported on the effect of an intragastric
balloon in order to reduce liver volume in super obese patients
prior to LRYGBP. Downsides of this method are high risk of
side effects and the invasive character of this method. There-
fore, this method should only be reserved for super obese
patients that require a considerable reduction of weight and
liver volume in order to facilitate LRYGBP.
Three studies [13,15,22] that investigated the effect of a
low calorie diet on liver volume reported that there were no
problems with the approach of the gastroesophageal junction
during surgery. In addition, pretreatment with omega-3 fatty
acids also resulted in an easy approach of the gastroesophage-
al junction and in a soft liver that could easily be manipulated
[21]. Since these two factors are the most important rationale
behind preoperative treatment with a low calorie diet, it is
remarkable that only four studies reported information on this
matter.
Six studies [12, 14–17, 21] reported information about
postoperative outcome. In general, there were no differences
in the effect of preoperative methods on postoperative out-
come. However, this review included not enough studies to
investigate the effect of preoperative methods to reduce liver
volume on postoperative outcome. In the most recent review
on this topic by Cassie et al. [24], the authors concluded that
there is not enough evidence to support the positive effects of
preoperative diets on postoperative outcome.
Our study had several limitations. First, only a small
number of studies with a relative small number of patients
were included. Second, it was difficult to make a proper
comparison of the studies because of their differences in
study design. Third, there were different radiographic
methods used to evaluate liver volume. In addition, some
studies measured whole liver volume and some only the
left hepatic lobe.
In our opinion, the best radiographic method to measure
liver size and fat content is magnetic resonance imaging
(MRI), because it gives an accurate estimation of liver size
and fat content. Computed tomography (CT) gives an accurate
estimation of liver size; however, liver CT is not the best
method to measure steatosis [25]. At this moment, ultrasound
(US) is most used to diagnose steatosis or steatohepatitis [26].
However, US is not the best method to measure liver size,
especially not in morbidly obese subjects.
In conclusion, this systematic review showed that pharma-
cological measures and an intragastric balloon are more effec-
tive than low calorie diets in reducing liver volume prior to
gastric bypass surgery. However, low calorie diet is the pref-
erable method to reduce liver volume, considering the level of
evidence and practical applicability. On average, low calorie
diets reduce liver size by 2.4 % per week; therefore, we would
recommend a low calorie diet of at least 4 weeks prior to
surgery. If patients do not tolerate a low calorie diet, alterna-
tives such as Nuvista® or omega-3 fatty acids should be con-
sidered. In the super obese, a gastric balloon is an effective
method to prepare these patients for LRYGBP. There is a need
for well-designed randomized studies with sufficient power in
order to confirm the effectiveness of preoperative methods to
reduce liver volume.
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